Concerns regarding clinical trials in haemophilia—Augmenting Iorio's “Research and policy implications of a recently published controlled study in previously untreated haemophilia patients at high risk of inhibitor development” Haemophilia (2017), 1-3 https

A. Farrugia; U. Schlenkrich

doi:10.1111/hae.13306

Concerns regarding clinical trials in haemophilia—Augmenting Iorio's “Research and policy implications of a recently published controlled study in previously untreated haemophilia patients at high risk of inhibitor development” Haemophilia (2017), 1-3 https

UWA Medical School

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e475-e476
Journal	Haemophilia
Volume	23
Issue number	5
DOIs	https://doi.org/10.1111/hae.13306
Publication status	Published - 1 Sept 2017

Access to Document

10.1111/hae.13306

Cite this

@article{c08a10527a8f4c04895d81d1103bb6c9,

title = "Concerns regarding clinical trials in haemophilia—Augmenting Iorio's “Research and policy implications of a recently published controlled study in previously untreated haemophilia patients at high risk of inhibitor development” Haemophilia (2017), 1-3 https",

author = "A. Farrugia and U. Schlenkrich",

year = "2017",

month = sep,

day = "1",

doi = "10.1111/hae.13306",

language = "English",

volume = "23",

pages = "e475--e476",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "Wiley-Blackwell",

number = "5",

}

Farrugia, A & Schlenkrich, U 2017, 'Concerns regarding clinical trials in haemophilia—Augmenting Iorio's “Research and policy implications of a recently published controlled study in previously untreated haemophilia patients at high risk of inhibitor development” Haemophilia (2017), 1-3 https', Haemophilia, vol. 23, no. 5, pp. e475-e476. https://doi.org/10.1111/hae.13306

Concerns regarding clinical trials in haemophilia—Augmenting Iorio's “Research and policy implications of a recently published controlled study in previously untreated haemophilia patients at high risk of inhibitor development” Haemophilia (2017), 1-3 https. / Farrugia, A.; Schlenkrich, U.
In: Haemophilia, Vol. 23, No. 5, 01.09.2017, p. e475-e476.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Concerns regarding clinical trials in haemophilia—Augmenting Iorio's “Research and policy implications of a recently published controlled study in previously untreated haemophilia patients at high risk of inhibitor development” Haemophilia (2017), 1-3 https

AU - Farrugia, A.

AU - Schlenkrich, U.

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85026447150&partnerID=8YFLogxK

U2 - 10.1111/hae.13306

DO - 10.1111/hae.13306

M3 - Letter

C2 - 28758308

AN - SCOPUS:85026447150

SN - 1351-8216

VL - 23

SP - e475-e476

JO - Haemophilia

JF - Haemophilia

IS - 5

ER -

Concerns regarding clinical trials in haemophilia—Augmenting Iorio's “Research and policy implications of a recently published controlled study in previously untreated haemophilia patients at high risk of inhibitor development” Haemophilia (2017), 1-3 https

Access to Document

Other files and links

Cite this